** Biotech's shares NVIV.O fall as much as 48 pct to
$1.75, hit record low
** Public offering priced at $2 per share and warrant, a
discount to Wednesday's close of $3.37 urn:newsml:reuters.com:*:nBw4Hj2pSa
** Gross proceeds expected to be $13.2 mln
** Up to Wednesday's close, stock had fallen ~95 pct over
the past year
(Reporting by Tamara Mathias in Bengaluru)
((Tamara.Mathias@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 1208; Reuters Messaging:
tamara.mathias.thomsonreuters.com@reuters.net))